Is EINECS 260-030-7 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use EINECS 260-030-7? Is EINECS 260-030-7 safe for nursing mother and child? Does EINECS 260-030-7 extracts into breast milk? Does EINECS 260-030-7 has any long term or short term side effects on infants? Can EINECS 260-030-7 influence milk supply or can EINECS 260-030-7 decrease milk supply in lactating mothers?
EINECS 260-030-7 lactation summary
- DrLact safety Score for EINECS 260-030-7 is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of EINECS 260-030-7 is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that EINECS 260-030-7 does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of EINECS 260-030-7 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About EINECS 260-030-7 usage in lactation
Alpha-glucosidase inhibitor which acts within the gastrointestinal tract without being absorbed, reducing intestinal absorption of glucose. Very low risk of hypoglycemia in monotherapy. Since the last update we have not found any published data on its excretion in breast milk. Its pharmacokinetic data (moderately elevated molecular weight and very low intestinal absorption) make it unlikely that it would pass to breast milk in significant amounts (Serrano 2014, Everett 1997). Diet, exercise, and breastfeeding improve blood sugar levels.
Answer by DrLact: About EINECS 260-030-7 usage in lactation
Because less than 2% of a dose of EINECS 260-030-7 is absorbed from the mother's gastrointestinal tract, it is unlikely that any drug reaches the infant through breastmilk.[1]
Alternate Drugs
Pioglitazone(Low Risk)
Nateglinide(Unsafe)
Metformin(Safe)
Empagliflozin(Unsafe)
Insulin(Safe)
Dapagliflozin(Unsafe)
Glyburide(Safe)
Alogliptin(Low Risk)
Glipizide(Safe)
Glimepiride(Unsafe)
Linagliptin(Low Risk)
Chlorpropamide(Low Risk)
Sitagliptin(Low Risk)
Acetohexamide(Low Risk)
Saxagliptin(Low Risk)
Acarbose(Safe)
Colesevelam(Safe)
Miglitol(Safe)
Tolbutamide(Safe)
Dulaglutide(Low Risk)
Rosiglitazone(Low Risk)
Liraglutide(Low Risk)
Repaglinide(Unsafe)